Nicola Hamilton-Whitaker

Dr. Nicola Hamilton-Whitaker

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2014 in Nature
Verified
Journal Article
Closed access
PDF file
CHCatherine N. Hall
Catherine N. Hall
CRClare Reynell
Clare Reynell
BGBodil Gesslein
Bodil Gesslein
NHNicola Hamilton-Whitaker
Nicola Hamilton-Whitaker
AMAnusha Mishra
Anusha Mishra
DADavid Attwell
David Attwell

1 April 2010 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
NHNicola Hamilton-Whitaker
Nicola Hamilton-Whitaker
DADavid Attwell
David Attwell

1 January 2010 in Frontiers in Neuroenergetics
Verified
Journal Article
Open access
NHNicola Hamilton-Whitaker
Nicola Hamilton-Whitaker
DADavid Attwell
David Attwell
CHCatherine N Hall
Catherine N Hall
Because regional blood flow increases in association with the increased metabolic demand generated by localized increases in neural activity, functional imaging researchers often assume that changes in blood flow are an accurate read-out of changes in underlying neural activity. An understanding of the mechanisms that link changes in neural activity to changes in blood flow is crucial for assessing the validity of this assumption, and for understanding the processes that can go wrong during disease states such as ischaemic stroke. Many studies have investigated the mechanisms of neurovascular regulation in arterioles but other evidence suggests that blood flow regulation can also occur in capillaries, because of the presence of contractile cells, pericytes, on the capillary wall. Here we review the evidence that pericytes can modulate capillary diameter in response to neuronal activity and assess the likely importance of neurovascular regulation at the capillary level for functional imaging experiments. We also discuss evidence suggesting that pericytes are particularly sensitive to damage during pathological insults such as ischaemia, Alzheimer’s disease and diabetic retinopathy, and consider the potential impact that pericyte dysfunction might have on the development of therapeutic interventions and on the interpretation of functional imaging data in these disorders.

2 March 2008 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
RKRagnhildur Káradóttir
Ragnhildur Káradóttir
NHNicola Hamilton-Whitaker
Nicola Hamilton-Whitaker
YBYamina Bakiri
Yamina Bakiri
DADavid Attwell
David Attwell

12 January 2011 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
JRJohanne Egge Rinholm
Johanne Egge Rinholm
NHNicola Hamilton-Whitaker
Nicola Hamilton-Whitaker
NKNicoletta Kessaris
Nicoletta Kessaris
WRWilliam D. Richardson
William D. Richardson
LBLinda H. Bergersen
Linda H. Bergersen
DADavid Attwell
David Attwell
In the gray matter of the brain, astrocytes have been suggested to export lactate (derived from glucose or glycogen) to neurons to power their mitochondria. In the white matter, lactate can support axon function in conditions of energy deprivation, but it is not known whether lactate acts by preserving energy levels in axons or in oligodendrocytes, the myelinating processes of which are damaged rapidly in low energy conditions. Studies of cultured cells suggest that oligodendrocytes are the cell type in the brain that consumes lactate at the highest rate, in part to produce membrane lipids presumably for myelin. Here, we use pH imaging to show that oligodendrocytes in the white matter of the rat cerebellum and corpus callosum take up lactate via monocarboxylate transporters (MCTs), which we identify as MCT1 by confocal immunofluorescence and electron microscopy. Using cultured slices of developing cerebral cortex from mice in which oligodendrocyte lineage cells express GFP (green fluorescent protein) under the control of the Sox10 promoter, we show that a low glucose concentration reduces the number of oligodendrocyte lineage cells and myelination. Myelination is rescued when exogenousl-lactate is supplied. Thus, lactate can support oligodendrocyte development and myelination. In CNS diseases involving energy deprivation at times of myelination or remyelination, such as periventricular leukomalacia leading to cerebral palsy, stroke, and secondary ischemia after spinal cord injury, lactate transporters in oligodendrocytes may play an important role in minimizing the inhibition of myelination that occurs.

21 February 2008 in Glia
Verified
Journal Article
Closed access
PDF file
NHNicola Hamilton-Whitaker
Nicola Hamilton-Whitaker
SVSteven Vayro
Steven Vayro
FKFrank Kirchhoff
Frank Kirchhoff
Alexei VerkhratskyAlexei Verkhratsky
Alexei Verkhratsky
JRJon Robbins
Jon Robbins
Arthur ButtArthur Butt
Arthur Butt